7/3/2020 7:58:54 AM
EC Grants Conditional Marketing Authorization For Gilead Sciences' Veklury For Treatment Of COVID-19
7/1/2020 8:34:43 AM
Gilead To Present New Data From HIV Research And
development Program
6/29/2020 7:05:40 AM
Gilead Issues Open Letter On Pricing Of Remdesivir; Sets Price For Governments Of Developed Countries Of $390/Vial
6/23/2020 8:33:52 AM
Gilead Sciences Secures Exclusive Option To Buy Pionyr Immunotherapeutics
6/22/2020 9:40:05 AM
Gilead To Trial Inhaled Version Of Remdesivir
6/16/2020 4:10:13 PM
Gilead Sciences Appoints Javier Rodriguez To Its Board Of Directors
6/12/2020 8:03:27 AM
Kite Gets EMA Approval For CAR T Cell Therapy Manufacturing Facility In Europe